Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Radiation Therapy
  •  Lymphoma
  •  Haemato-Oncology
  •  Adjuvant Therapy
  •  Chemotherapy and Radiotherapy
  •  Radiological Techniques and Scans
  •  Radiation Oncology
  •  Head and Neck Oncology

Abstract

Citation: Clin Oncol. 2021;6(1):1801.DOI: 10.25107/2474-1663.1801

Percutaneous Cryoablation for Clinical Stage I Non-Small Cell Lung Cancer: Histology, Results, and Safety

Frank A Baciewicz Jr, Hakob Kocharyan, Deborah Hackstock, Lance Heilbrun, Hussein D Aoun, Fulvio Lonardo and Peter J Littrup

Department of Cardiothoracic Surgery, Wayne State University, USA
Karmanos Cancer Institute, USA
Department of Radiology, Detroit Medical Center/Wayne State University, USA
Department of Radiology, Karmanos Cancer Institute/Wayne State University, USA
Department of Pathology, Wayne State University, USA
Department of Diagnostic Imaging, Ascension Medical Center, Rochester, USA

*Correspondance to: Frank A Baciewicz Jr 

 PDF  Full Text Research Article | Open Access

Abstract:

Objectives: Lobectomy for clinical stage I lung cancer has an 80% to 90% 5-year survival rate but has morbidity and mortality risks. Not all clinical stage I patients are surgical candidates and some refuse surgery. This study’s primary endpoint was to describe the histologic outcome of stage I lung cancer patients treated by percutaneous CT guided cryoablation (PCA).
Methods: Histologically confirmed, clinically staged stage I tumors underwent PCA with standard cryo probes (Endocare, Irvine, Cal). Intraprocedure CT documentation of visible ice (-0 degree Celsius) extending beyond the tumor margins (~1 cm) was performed. Resection of the ablation zone/tumor and lymph node dissection with extensive histologic review was then performed.
Results: Nine patients (7 male, 2 female), median age 65.9 years (range 52 to 78) with mean CT scan tumor diameter 1.7 cm ± 0.3 cm underwent PCA for 4 right upper lobe, 4 left upper lobe and 1 right lower lobe tumors. There were 2 grade 3 CTCAE and 3 grade 1-2 CTCAE complications. Two patients required admission after PCA. Surgical resection via thoracotomy was performed a median of 64.6 days after PCA. Two resections showed only 1 microscopic focus of tumor (≤ 1 mm). Only one showed macroscopic residual tumor (1 cm) and the remaining 6 showed no tumor. The only patient with macroscopic residual disease had pathologic stage IIIB.
Conclusion: Outpatient PCA in clinical stage I Non-Small Cell Lung Cancer (NSCLC) offers a safe, feasible treatment with complete local tumor eradiation in 6/9 patients.

Keywords:

Cite the Article:

Baciewicz FA Jr, Kocharyan H, Hackstock D, Heilbrun L, Aoun HD, Lonardo F, et al. Percutaneous Cryoablation for Clinical Stage I Non-Small Cell Lung Cancer: Histology, Results, and Safety. Clin Oncol. 2021;6:1801..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Roles of Histone Modifications in Gastrointestinal Tumorigenesis
 Abstract  PDF  Full Text
A Randomised Controlled Trial to Determine the Effect of Triptorelin on Reduction of Prostate Volume PreRadiotherapy Compared with Standard Therapy (Goserelin)
 Abstract  PDF  Full Text
View More...